10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: role of thromboxane and purinergic receptors

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Uridine adenosine tetraphosphate (Up 4A), a novel endothelium-derived vasoactive agent, is proposed to play a role in cardiovascular disorders and induces aortic contraction through activation of cyclooxygenases (COX). We and others demonstrated that activation of A 1 or A 3 adenosine receptors (AR) results in vascular contraction via thromboxane (TX) A 2 production. However, the mechanisms of Up 4A-induced vascular contraction in mouse aorta are not understood. We hypothesize that Up 4A-induced aortic contraction is through COX-derived TXA 2 production, which requires activation of A 1 and/or A 3AR. Concentration responses to Up 4A were conducted in isolated aorta. The TXB 2 production, a metabolite of TXA 2, was also measured. Up 4A (10 −9–10 −5 M) produced a concentration-dependent contraction >70%, which was markedly attenuated by COX and COX1 but not by COX2 inhibition. Notably, Up 4A-induced aortic contraction was blunted by both TX synthase inhibitor ozagrel and TXA 2 receptor (TP) antagonist SQ29548. Surprisingly, A 3AR deletion had no effect on Up 4A-induced contraction. Moreover, A 1AR deletion or antagonism as well as A 1/A 3AR deletion potentiated Up 4A-induced aortic contraction, suggesting a vasodilator influence of A 1AR. In contrast, non-selective purinergic P2 receptor antagonist PPADS significantly blunted Up 4A-induced aortic contraction to a similar extent as selective P2X 1R antagonist MRS2159, the latter of which was further reduced by addition of ozagrel. Endothelial denudation almost fully attenuated Up 4A-induced contraction. Furthermore, Up 4A (3 µM) increased TXB 2 formation, which was inhibited by either MRS2159 or ozagrel. In conclusion, Up 4A-induced aortic contraction depends on activation of TX synthase and TP, which partially requires the activation of P2X 1R but not A 1 or A 3 AR through an endothelium-dependent mechanism.

          Graphical Abstract

          Related collections

          Author and article information

          Journal
          101130615
          29859
          Vascul Pharmacol
          Vascul. Pharmacol.
          Vascular pharmacology
          1537-1891
          1879-3649
          6 May 2015
          25 April 2015
          October 2015
          01 October 2016
          : 73
          : 78-85
          Affiliations
          [a ]Department of Physiology and Pharmacology, Center for Cardiovascular and Respiratory Sciences, Clinical and Translational Science Institute, West Virginia University, Morgantown, WV, USA
          [b ]Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
          Author notes
          [* ]Corresponding author: S. Jamal Mustafa, Ph.D., Department of Physiology and Pharmacology, West Virginia University, PO Box 9104, Morgantown, WV 26506-9104, Tel: +1-304-2935830, Fax: +1-304-2937038, sjmustafa@ 123456hsc.wvu.edu
          Article
          PMC4578990 PMC4578990 4578990 nihpa684822
          10.1016/j.vph.2015.04.009
          4578990
          25921923
          6a7b7afc-5999-49cb-bc00-6f46e5e30e74
          History
          Categories
          Article

          vasoconstriction,endothelium,thromboxane,P2X1 ,mouse aorta,Up4A
          vasoconstriction, endothelium, thromboxane, P2X1 , mouse aorta, Up4A

          Comments

          Comment on this article